GNRC vs TERN · P/E 82, rev $4.21B vs $6.12B cap
Generac Holdings Inc (GNRC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GNRC currently screens at market cap $15.40B and trailing P/E 82.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GNRC and TERN stock pages for the full models.
Not investment advice.